TLE1 and carcinoma: Zaccarini et al. evaluated TLE1 and CD99 expression in various carcinomas and evaluated the expression of the SS18 (SYT) gene rearrangement in tumors with TLE1 and/or CD99 expression in 100 various carcinomas [8].